GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SynBiotic SE (XTER:SBX) » Definitions » ROA %

SynBiotic SE (XTER:SBX) ROA % : 0.00% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is SynBiotic SE ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. SynBiotic SE's annualized Net Income for the quarter that ended in Dec. 2023 was €0.00 Mil. SynBiotic SE's average Total Assets over the quarter that ended in Dec. 2023 was €37.77 Mil. Therefore, SynBiotic SE's annualized ROA % for the quarter that ended in Dec. 2023 was 0.00%.

The historical rank and industry rank for SynBiotic SE's ROA % or its related term are showing as below:

XTER:SBX' s ROA % Range Over the Past 10 Years
Min: -64.5   Med: -26.6   Max: -4.99
Current: -64.5

During the past 6 years, SynBiotic SE's highest ROA % was -4.99%. The lowest was -64.50%. And the median was -26.60%.

XTER:SBX's ROA % is ranked worse than
91% of 1045 companies
in the Drug Manufacturers industry
Industry Median: 1.8 vs XTER:SBX: -64.50

SynBiotic SE ROA % Historical Data

The historical data trend for SynBiotic SE's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynBiotic SE ROA % Chart

SynBiotic SE Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
Get a 7-Day Free Trial -5.46 -4.99 -26.60 -48.11 -28.15

SynBiotic SE Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Dec23
ROA % Get a 7-Day Free Trial Premium Member Only -2.21 -46.79 -4.45 -96.30 -

Competitive Comparison of SynBiotic SE's ROA %

For the Drug Manufacturers - Specialty & Generic subindustry, SynBiotic SE's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SynBiotic SE's ROA % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SynBiotic SE's ROA % distribution charts can be found below:

* The bar in red indicates where SynBiotic SE's ROA % falls into.



SynBiotic SE ROA % Calculation

SynBiotic SE's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=-10.631/( (40.624+34.918)/ 2 )
=-10.631/37.771
=-28.15 %

SynBiotic SE's annualized ROA % for the quarter that ended in Dec. 2023 is calculated as:

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Dec. 2022 )+Total Assets (Q: Dec. 2023 ))/ count )
=0/( (40.624+34.918)/ 2 )
=0/37.771
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2023) net income data. ROA % is displayed in the 30-year financial page.


SynBiotic SE  (XTER:SBX) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=0/37.771
=(Net Income / Revenue)*(Revenue / Total Assets)
=(0 / 0)*(0 / 37.771)
=Net Margin %*Asset Turnover
=N/A %*0
=0.00 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


SynBiotic SE ROA % Related Terms

Thank you for viewing the detailed overview of SynBiotic SE's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


SynBiotic SE Business Description

Traded in Other Exchanges
Address
Barer Strasse 7, Munich, BY, DEU, 80333
SynBiotic SE is engaged in the development of Phyto-cannabinoids and other herbal compounds concentrated molecules as well as the development of wellness products. The company engages in synthetic production, drug development, cannabinoids, dietary supplements and cosmetic products. Geographical presence in Germany, Austria, UK, Switzerland and Other countries. Majority of its revenue comes from domestic market.
Executives
Daniel Kruse Geschäftsführender Direktor

SynBiotic SE Headlines

No Headlines